BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35557546)

  • 1. Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in
    Song MH; Yoo J; Oh JG; Kook H; Park WJ; Jeong D
    Front Cardiovasc Med; 2022; 9():763544. PubMed ID: 35557546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged
    Kepreotis SV; Oh JG; Park M; Yoo J; Lee C; Mercola M; Hajjar RJ; Jeong D
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102174. PubMed ID: 38584818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.
    Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM
    J Neurol Sci; 2008 Jan; 264(1-2):106-11. PubMed ID: 17889902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
    Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
    Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
    Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
    Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
    Lopez JR; Kolster J; Zhang R; Adams J
    J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined gene therapy via VEGF and mini-dystrophin synergistically improves pathologies in temporalis muscle of dystrophin/utrophin double knockout mice.
    Xin C; Chu X; Wei W; Kuang B; Wang Y; Tang Y; Chen J; You H; Li C; Wang B
    Hum Mol Genet; 2021 Jun; 30(14):1349-1359. PubMed ID: 33987645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin.
    Chan MC; Rowe GC; Raghuram S; Patten IS; Farrell C; Arany Z
    Skelet Muscle; 2014 Jan; 4(1):2. PubMed ID: 24447845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired respiratory function in mdx and mdx/utrn(+/-) mice.
    Huang P; Cheng G; Lu H; Aronica M; Ransohoff RM; Zhou L
    Muscle Nerve; 2011 Feb; 43(2):263-7. PubMed ID: 21254093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD).
    Sengupta K; Loro E; Khurana TS
    Sci Rep; 2020 Dec; 10(1):21492. PubMed ID: 33298994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy.
    Janssen PM; Murray JD; Schill KE; Rastogi N; Schultz EJ; Tran T; Raman SV; Rafael-Fortney JA
    PLoS One; 2014; 9(2):e88360. PubMed ID: 24551095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice.
    Strimpakos G; Corbi N; Pisani C; Di Certo MG; Onori A; Luvisetto S; Severini C; Gabanella F; Monaco L; Mattei E; Passananti C
    J Cell Physiol; 2014 Sep; 229(9):1283-91. PubMed ID: 24469912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/
    Kennedy TL; Guiraud S; Edwards B; Squire S; Moir L; Babbs A; Odom G; Golebiowski D; Schneider J; Chamberlain JS; Davies KE
    Mol Ther Methods Clin Dev; 2018 Dec; 11():92-105. PubMed ID: 30417024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.